ClinicalTrials.Veeva

Menu

Genicular Nerve Block Versus Its Combination With Infiltration Between Popliteal Artery and Capsule of Posterior Knee

Z

Zagazig University

Status

Enrolling

Conditions

Postoperative Pain

Treatments

Procedure: GNB plus standard analgesia
Procedure: GNB plus IPACK block plus standard analgesia
Drug: standard analgesia (paracetamol and meloxicam)

Study type

Interventional

Funder types

Other

Identifiers

NCT05672784
9577/19-9-2022

Details and patient eligibility

About

Comparison of the analgesic and physical recovery effect of genicular nerve block (GNB) alone and (GNB + infiltration between popliteal artery and posterior capsule of the knee (IPACK) in patients undergoing total knee replacement

Full description

Comparison of preemptive analgesia of (GNB) with (GNB+ IPACK) on postoperative pain control and recovery of knee physical activity in patient undergoing total knee replacement.

Enrollment

63 estimated patients

Sex

All

Ages

21 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • Adult patients aged between 21 to 60 years
  • undergoing primary unilateral elective total knee arthroplasty under spinal anesthesia
  • Having informed consents
  • patients with physical status ASA I & II
  • both genders
  • body mass index less than 40 kg/m2.

Exclusion criteria

  • patients with Peripheral vascular disease
  • patients with history of allergy to local anesthesia or opioid analgesia,
  • those on anti-platelet, anticoagulant or B blocker drugs
  • Patients with acute decompensated heart failure
  • Patients with hypertension
  • Patients with heart block
  • Patients with coronary disease
  • Patients with bronchial asthma
  • Patients with bleeding disorders
  • Patients with compromised renal or hepatic function
  • pregnant female.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

63 participants in 3 patient groups

C group
Active Comparator group
Description:
the patients will take standard analgesia ( meloxicam (15 mg) once a day + paracetamol 1gm /3 times a day). ,with no nerve block
Treatment:
Drug: standard analgesia (paracetamol and meloxicam)
G group
Active Comparator group
Description:
the patients will take standard analgesia plus GNB
Treatment:
Drug: standard analgesia (paracetamol and meloxicam)
Procedure: GNB plus standard analgesia
GI group
Active Comparator group
Description:
the patients will take standard analgesia plus GNB plus IPACK
Treatment:
Drug: standard analgesia (paracetamol and meloxicam)
Procedure: GNB plus IPACK block plus standard analgesia

Trial contacts and locations

1

Loading...

Central trial contact

Heba M Fathi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems